Mylan Inc.
NASDAQ: MYL
$15.86
+$0.00 (+0.0%)
Closing price November 19, 2020
Many blue-chip leaders did not participate in the best August in 24 years. In fact, many of the top stocks are still trading down so far this year. These 11 just refuse to participate in the greatest...
Published:
24/7 Wall St. has put together a preview of Applied Materials, Cisco, Norwegian Cruise Line and some of the other most anticipated quarterly reports due this week.
Published:
Friday's top analyst upgrades and downgrades included American Airlines, Chipotle Mexican Grill, Ericsson, Microsoft, Mylan, Novavax, Pfizer, Procter & Gamble, Qualcomm, Square and Starbucks.
Published:
Last Updated:
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this coronavirus and here is where their stocks stand now.
Published:
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this novel coronavirus. Here's how they fared as the week wound down.
Published:
Mylan stock pulled back on Friday after it reported mixed fourth-quarter financial results late Thursday.
Published:
Investors are not used to hearing is the word "biotech" used in the same sentence as anything to do with Warren Buffett and Berkshire Hathaway. Yet the portfolio managers have purchased shares of...
Published:
Here are 20 biotechnology and pharmaceutical stocks that have been given big analyst upside targets for 2020.
Published:
Here are 11 biotech and pharma stocks that have been given big analyst upside targets for 2020.
Published:
Thursday's top analyst upgrades, downgrades and initiations included Citigroup, CommScope, CVS Health, CyberArk, Emerson Electric, Match, Mylan, Qualcomm, Roku, Square, Twitter and Vonage.
Published:
Of the 40 worst performers in the S&P 500 so far in 2019, 11 are tied to oil and gas, 10 tied mostly to retailing of apparel and accessories, and six are tied to pharmaceuticals and biotech.
Published:
Mylan released its second-quarter financial results before the markets opened on Monday. The pharma giant also announced a major update to its business involving Pfizer and that CEO Heather Bresch is...
Published:
The top analyst upgrades, downgrades and initiations on Tuesday included Agilent Technologies, Allergan, Beyond Meat, Canopy Growth, Dollar Tree, Facebook, Luckin Coffee, Lyft, Mylan, Symantec,...
Published:
The top analyst upgrades, downgrades and initiations seen on Wednesday included Chipotle Mexican Grill, Hasbro, Inogen, Lending Club, Mosaic, Mylan, Pinterest, U.S. Steel and Walt Disney.
Published:
Mylan released mixed first-quarter financial results before the markets opened on Tuesday, and share plunged afterward.
Published:
Last Updated: